Key result
OAC monotherapy cuts bleeding without increasing ischemic events compared with OAC plus antiplatelet therapy.
Why the study?
Patients receiving therapeutic OAC often have indications for antiplatelet therapy, and combining antiplatelet agents with therapeutic anticoagulation historically increased bleeding risk without a proven reduction in thrombosis.
Does oral anticoagulation monotherapy reduce bleeding without increasing ischemic events compared with combination therapy of oral anticoagulation plus an antiplatelet agent in adults with atrial fibrillation and stable coronary artery disease, cerebrovascular disease, or prosthetic heart valves?
Systematic Review
Does oral anticoagulation monotherapy reduce bleeding without increasing ischemic events compared with combination therapy of oral anticoagulation plus an antiplatelet agent in adults with atrial fibrillation and stable coronary artery disease, cerebrovascular disease, or prosthetic heart valves?
This scoping review of 11 RCTs demonstrates that oral anticoagulation monotherapy reduces bleeding without increasing ischemic events compared to combination therapy with an antiplatelet agent in patients with atrial fibrillation and stable coronary artery disease or post-TAVR, while evidence remains limited for cerebrovascular disease and mechanical heart valves.
Answers are grounded in this paper and cite their sources.
May favor OAC monotherapy to reduce bleeding in AF with stable CAD; leaves open evidence gaps for mechanical valves.
Patients receiving therapeutic oral anticoagulation (OAC) often have indications for antiplatelet therapy. Historically, antiplatelet agents have been used alongside therapeutic anticoagulation, increasing the risk of bleeding without a proven reduction in thrombosis. This scoping review summarizes recent evidence evaluating OAC monotherapy compared with combination therapy consisting of OAC plus antiplatelet agent among patients with atrial fibrillation and stable coronary artery disease, cerebrovascular disease, and prosthetic heart valves. We searched PubMed, Embase, CENTRAL, and International Pharmaceutical Abstracts to identify randomized controlled trials (RCTs) evaluating these strategies. Included studies enrolled adults receiving therapeutic anticoagulation across different cardiovascular disease states that reported efficacy and safety outcomes. Two reviewers independently screened studies and extracted data, with disagreements resolved by a third reviewer. Published subgroup analyses of included RCTs were also reviewed. After screening 10,008 records, 11 RCTs met inclusion criteria. Evidence supporting OAC monotherapy was observed in patients with atrial fibrillation and stable coronary artery disease; OAC monotherapy consistently reduced bleeding without increasing ischemic events compared with combination therapy. Similar reductions in bleeding were observed in patients with cerebrovascular disease, although evidence remains limited by small sample size and early trial termination. Among patients undergoing transcatheter aortic valve replacement with an indication for chronic anticoagulation, OAC monotherapy reduced bleeding without compromising ischemic outcomes. Evidence supporting discontinuation of antiplatelet therapy in patients with mechanical heart valves remains limited. Additional RCTs are needed to better define the role of antiplatelet therapy in cerebrovascular disease, prosthetic heart valves, and other high-risk populations.
No takes yet. Share an insight, caveat, or question.
Ammar et al. (2026) conducted a systematic review in Cardiovascular conditions requiring therapeutic oral anticoagulation (atrial fibrillation with stable coronary artery disease, cerebrovascular disease, and prosthetic heart valves). Oral anticoagulation (OAC) monotherapy vs. Combination therapy (OAC plus antiplatelet agent) was evaluated on Bleeding and ischemic events. Across 11 RCTs, OAC monotherapy reduced bleeding without increasing ischemic events vs OAC plus antiplatelet therapy in AF with stable CAD and TAVR, with limited evidence for mechanical valves.
Synapse has enriched 10 related papers. Consider them for comparative context: